Search
There are 847 result(s) for ultra processed
-
High blood pressure - HYVET
The HYVET trial aimed to find out if it was safe to prescribe high blood pressure medication to people over 80.
-
Our response to the Daily Telegraph story on charity expenditure
An article in a national newspaper has criticised a number of UK charities, including the BHF, for not spending enough income on charitable activities. We believe the article gives a distorted view of how we spend your donations, which help fund over half of heart research at UK universities. Read our full response to the story here.
-
RESEARCH
Developing a new type of MRI scanner to study the human heartUniversity of Aberdeen | Professor Dana Dawson
Magnetic resonance imaging (MRI) is a scanning technique that uses strong magnetic fields and radio waves to produce pictures of organs and tissues in the body. A fundamental principle of MRI is that the magnetic field remains fixed – u...
-
RESEARCH
Equipping scientists with state-of-the-art technology for analysis of small molecules in heart and circulatory diseasesCardiff University | Professor Valerie O'Donnell
It is essential for scientists studying heart and circulatory diseases to be able to quickly and comprehensively analyse all the different types of fats (known as lipids) in a sample of blood or tissue. The most effective technology for doi...
-
Stopping life-threatening problems in people with Marfan syndrome
Some people with Marfan syndrome have weak blood vessels which are at risk of bursting. This can be fatal. We’ve been funding research to stop this.
-
Lewis' story
We hear from Lewis Barnet about his experience of volunteering with the BHF as somebody who has Cerebral Palsy, a lifelong condition that affects movement and co-ordination.
-
Myocardial perfusion scan
This page explains what a myocardial perfusion scan (MPS) is, what it can show and what happens during an MPS test.
-
Refunds and exchanges
Find out what our refund and exchange policy is when you buy from British Heart Foundation shops and home stores.
-
Landmark study finds no benefit of routine use of cerebral embolic protection devices on TAVI stroke risk
A £2.3 million clinical trial we funded has found that devices designed to reduce the risk of TAVI patients having a stroke have no impact on their stroke risk.